PapersPMID:41315088
Ketone supplementation dose-dependently lowers postprandial blood glucose, lipid and ghrelin levels in individuals with type 2 diabetes: a randomised crossover study.
What moved
1 findingHow to read these marks →“We found that the iAUC for glucose decreased by 36% (95% CI 14, 57) with KE and 22% (95% CI 1, 44) with KS compared with placebo.”
- Study
- crossover
- Dose studied
- 30 g ketone salts, 30 min before a mixed meal test
- Population
- Adults with type 2 diabetes treated with metformin monotherapy or a lifestyle intervention alone; study 1, participant-blind crossover, mixed meal test
Study record
- Design
- crossover trial
- Species
- human
- Population
- Individuals with type 2 diabetes treated with metformin monotherapy or lifestyle intervention alone; study 1 (n=14) compared a ketone monoester (KE), ketone salts (KS; salt form not stated in the abstract) and placebo before a mixed meal; study 2 (n=10) compared KE doses before an OGTT. The ketone monoester is outside this node's boundary; the ketone salts arm is in it (abstract only)
- Participants
- 14
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 7